Skip to main content

NewLeaf Symbiotics

St Louis, United States

NewLeaf Symbiotics is an agtech company focused on developing sustainable agricultural products using bacteria and related microbes.

$45.0M raised
Dec 2023
Series D

Top Investors

S2G InvestmentsPangaea VenturesLewis & Clark VenturesOpen PrairieLeaps by Bayer

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NewLeaf Symbiotics

How much funding has NewLeaf Symbiotics raised?
NewLeaf Symbiotics has raised $45.0M in total funding. The most recent round was Series D. The last funding was announced in December 2023.
Who are NewLeaf Symbiotics's investors?
NewLeaf Symbiotics's investors include S2G Investments, Pangaea Ventures, Lewis & Clark Ventures, Open Prairie, Leaps by Bayer.
Where is NewLeaf Symbiotics headquartered?
NewLeaf Symbiotics is headquartered in St Louis, United States.
What does NewLeaf Symbiotics do?
NewLeaf Symbiotics is an agtech company focused on developing sustainable agricultural products using bacteria and related microbes.
What stage is NewLeaf Symbiotics at?
NewLeaf Symbiotics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"NewLeaf Symbiotics — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/newleaf-symbiotics. Accessed June 4, 2026.
APA
VCBacked. (2023). NewLeaf Symbiotics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/newleaf-symbiotics
Wikipedia (cite web)
{{cite web |title=NewLeaf Symbiotics — Funding & Investors |url=https://www.vcbacked.co/company/newleaf-symbiotics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .